Natural killer (NK) immune cells are essential for human defense against infection and malignancy. Armed at baseline to mediate cytotoxicity, NK cells survey their environment, precisely targeting their cytolytic effects to individual cancerous or virus-infected cells. Through a tightly regulated step-wise process termed """"""""directed secretion"""""""", NK cells mobilize highly specialized large organelles (lytic granules) to the NK/target cell interface, known as the immune synapse (IS). The proposed work addresses the following three critical challenges to accessing and controlling directed secretion for NK cell cytotoxicity: 1) organizing lytic granules for focused and efficient delivery;2) orchestrating the cortical cytoskeleton to permit lytic granule egress;and 3) facilitating transit of lytic granules to the synaptic membrane. First, lytic granules converge to the microtubule organization center (MTOC) prior to polarizing to the NK cell IS. The proposed work will identify the signal and cellular inputs that drive lytic granule convergence and specifically determine whether convergence makes NK cells more efficient killers, less likely to kill """"""""innocent bystanders"""""""", and more capable of mediating serial kills. Second, current paradigms suggest that lytic granule egress occurs through a single large clearance in the actin cortex. High-resolution imaging modalities, however, suggest that lytic granules exploit smaller, specifically generated hypodense conduits in the filamentous (F)-actin network. Combining highly quantitative imaging with a novel degranulation indicator and innovative human NK cell manipulation techniques, the proposed work will further define the nature and requirement for these conduits for degranulation. Lastly, recently identified NK cell lytic granule-based motor complexes are required for the lytic granule's final approach to the synaptic membrane. Live-cell imaging and adoptive transfer-style experiments using lytic granules and NK cell cortices will define the mechanisms by which lytic granule-associated myosin-IIA enables granules to find, move through, and/or form F-actin conduits. The specific role of the myosin-IIA tail and myosin-IIA phosphorylation in these functions will be tested using a combination of immunological and biochemical assays. In the absence of strict control of directed secretion, NK cells would lose efficiency and indiscriminately kill neighboring tissue and healthy cells, posing a danger to the human host. The proposed work will redefine fundamental paradigms as to how access to cytotoxicity is controlled, define new cellular checkpoints in NK cell function, and provide novel insights into the basic cell biological processes that govern immunity. Better understanding the immunoregulatory mechanisms controlling the precise step-wise progression to cytotoxicity will enable therapeutic manipulation of NK cell function in the context of human disease.

Public Health Relevance

Natural Killer (NK) immune cells precisely target and destroy cancerous and virus-infected cells. The proposed work will define the sub-cellular mechanisms governing the directionality and efficiency of the NK cell killing machinery. Understanding these processes will enable therapeutic control of NK cell defense against malignancy and infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI067946-06
Application #
8469256
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Miller, Lara R
Project Start
2005-12-01
Project End
2016-03-31
Budget Start
2012-06-04
Budget End
2013-03-31
Support Year
6
Fiscal Year
2012
Total Cost
$249,058
Indirect Cost
$90,725
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Gunesch, Justin T; Angelo, Laura S; Mahapatra, Sanjana et al. (2018) Genome-wide analyses and functional profiling of human NK cell lines. Mol Immunol :
Mamonkin, Maksim; Mukherjee, Malini; Srinivasan, Madhuwanti et al. (2018) Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies. Cancer Immunol Res 6:47-58
Gwalani, Lavesh A; Orange, Jordan S (2018) Single Degranulations in NK Cells Can Mediate Target Cell Killing. J Immunol 200:3231-3243
Chinn, Ivan K; Eckstein, Olive S; Peckham-Gregory, Erin C et al. (2018) Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood 132:89-100
Carisey, Alexandre F; Mace, Emily M; Saeed, Mezida B et al. (2018) Nanoscale Dynamism of Actin Enables Secretory Function in Cytolytic Cells. Curr Biol 28:489-502.e9
Ruiz-García, Raquel; Vargas-Hernández, Alexander; Chinn, Ivan K et al. (2018) Mutations in PI3K110? cause impaired natural killer cell function partially rescued by rapamycin treatment. J Allergy Clin Immunol 142:605-617.e7
Samaha, Heba; Pignata, Antonella; Fousek, Kristen et al. (2018) A homing system targets therapeutic T cells to brain cancer. Nature 561:331-337
Jacquemet, Guillaume; Paatero, Ilkka; Carisey, Alexandre F et al. (2017) FiloQuant reveals increased filopodia density during breast cancer progression. J Cell Biol 216:3387-3403
Lesteberg, Kelsey; Orange, Jordan; Makedonas, George (2017) Recycling endosomes in human cytotoxic T lymphocytes constitute an auxiliary intracellular trafficking pathway for newly synthesized perforin. Immunol Res 65:1031-1045
Mace, Emily M; Bigley, Venetia; Gunesch, Justin T et al. (2017) Biallelic mutations in IRF8 impair human NK cell maturation and function. J Clin Invest 127:306-320

Showing the most recent 10 out of 69 publications